We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-3.68%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$982M
AUM Growth
+$92.9M
Cap. Flow
+$134M
Cap. Flow %
13.65%
Top 10 Hldgs %
4.69%
Holding
1,940
New
653
Increased
414
Reduced
285
Closed
576

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$4.61M
2
DPZ icon
Domino's
DPZ
+$3.96M
3
BRKR icon
Bruker
BRKR
+$3.65M
4
TJX icon
TJX Companies
TJX
+$3.62M
5
SBUX icon
Starbucks
SBUX
+$3.58M

Sector Composition

Rank Sector Weight
1 Healthcare 17.3%
2 Industrials 16.2%
3 Technology 12.7%
4 Financials 11.7%
5 Consumer Discretionary 9.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HA
151
DELISTED
Hawaiian Holdings, Inc.
HA
$1.4M 0.14%
64,833
+30,104
+87% +$617K
CMRE icon
152
Costamare
CMRE
$1.8B
$1.4M 0.14%
90,479
-63,578
-41% -$820K
MXL icon
153
MaxLinear
MXL
$6.37B
$1.4M 0.14%
+28,472
New +$1.38M
UBX
154
DELISTED
Unity Biotechnology
UBX
$1.4M 0.14%
46,737
+26,149
+127% +$923K
ATVI
155
DELISTED
Activision Blizzard
ATVI
$1.4M 0.14%
+18,097
New +$1.51M
CYTK icon
156
Cytokinetics
CYTK
$11B
$1.39M 0.14%
+38,942
New +$1.15M
MCRB icon
157
Seres Therapeutics
MCRB
$47.9M
$1.39M 0.14%
+10,001
New +$1.96M
AB icon
158
AllianceBernstein
AB
$3.47B
$1.39M 0.14%
28,048
+3,520
+14% +$173K
KBR icon
159
KBR
KBR
$4.74B
$1.39M 0.14%
+35,310
New +$1.37M
VATE icon
160
INNOVATE Corp
VATE
$101M
$1.39M 0.14%
33,860
+21,483
+174% +$803K
DCI icon
161
Donaldson
DCI
$11.4B
$1.39M 0.14%
24,155
+12,981
+116% +$837K
SUI icon
162
Sun Communities
SUI
$14.7B
$1.39M 0.14%
+7,491
New +$1.45M
QNCX icon
163
Quince Therapeutics
QNCX
$28.9M
$1.38M 0.14%
75
+9
+14% +$143K
AZZ icon
164
AZZ Inc
AZZ
$4.53B
$1.36M 0.14%
25,532
+18,030
+240% +$948K
CRK icon
165
Comstock Resources
CRK
$3.88B
$1.36M 0.14%
131,039
-92,283
-41% -$625K
BSM icon
166
Black Stone Minerals
BSM
$3.02B
$1.35M 0.14%
112,289
-49,887
-31% -$529K
OVV icon
167
Ovintiv
OVV
$16.6B
$1.35M 0.14%
41,148
+34,645
+533% +$957K
KALU icon
168
Kaiser Aluminum
KALU
$2.8B
$1.35M 0.14%
12,410
+10,335
+498% +$1.23M
TUP
169
DELISTED
Tupperware Brands Corporation
TUP
$1.35M 0.14%
+63,854
New +$1.43M
GLPI icon
170
Gaming and Leisure Properties
GLPI
$12.8B
$1.35M 0.14%
+29,110
New +$1.39M
REGN icon
171
Regeneron Pharmaceuticals
REGN
$79.5B
$1.35M 0.14%
2,228
+1,850
+489% +$1.15M
QGEN icon
172
Qiagen
QGEN
$8.61B
$1.34M 0.14%
+24,469
New +$1.36M
DIA icon
173
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$46.3B
$1.33M 0.14%
3,933
+686
+21% +$240K
FLR icon
174
Fluor
FLR
$6.81B
$1.33M 0.14%
83,021
+67,189
+424% +$1.1M
BCOV
175
DELISTED
Brightcove, Inc.
BCOV
$1.33M 0.14%
114,927
-6,244
-5% -$75.5K

Similar funds

GSA Capital Partners's Q3 2021 Portfolio in Review

As of Q3 2021, GSA Capital Partners held 1,940 positions worth $982M, up 10% from $889M the previous quarter. Its ten largest holdings account for 4.7% of the portfolio.

GSA Capital Partners deployed $134M of net new capital in Q3 2021, opening 653 new positions and adding to 414 existing holdings. Its largest new stake was Openlane: 280,405 shares worth $4.6M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 15% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Amazon, an estimated $4.61M trimmed.

  • GSA Capital Partners's largest Q3 2021 buy was Openlane: 280,405 shares worth $4.6M.
  • GSA Capital Partners added most to BridgeBio Pharma in Q3 2021, an estimated $4.54M increase.
  • GSA Capital Partners's biggest Q3 2021 reduction was Amazon, cutting an estimated $4.61M.
  • GSA Capital Partners fully exited TJX Companies in Q3 2021, selling an estimated $3.62M.
  • GSA Capital Partners's ten largest holdings make up 4.7% of its $982M portfolio in Q3 2021.
  • GSA Capital Partners opened 653 new positions and closed 576 in Q3 2021.
  • GSA Capital Partners's portfolio value rose 10% quarter-over-quarter to $982M.

Based on GSA Capital Partners's 13F filing for Q3 2021, filed 12 Nov 2021.